In collaboration with Matatū and High Performance Sport NZ (HPSNZ), University of Canterbury | Te Whare Wānanga o Waitaha (UC ...

A UC research team is exploring how hormones affect elite female athletes’ performance, breaking new ground for women in ...

Discover the top 10 risky factors that increase your chance of developing arthritis, from genetics to lifestyle choices, and ...

Five years since the start of the COVID-19 pandemic, long COVID — one of the most mysterious and debilitating consequences of the virus — remains with us, and is disproportionately affecting women. An ...

Ended 2024 with $71.1 million of cash and cash equivalents and no debtConference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8:30 ...

Autism spectrum disorder (ASD) was first described in 1943. In the current medical nomenclature, it covers autism, atypical ...

Depression is a mental health condition that affects 280 million people worldwide. It is twice as common in women than men ...

HealthDay News — Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in US transgender, nonbinary, and gender-diverse (TGD) ...

Red flag: Everybody goes through that. If your symptoms aren’t that bad, don’t worry about it. Red flag: If you’re still ...

Mice lacking the secreted hormone, CTRP10, represent a unique female model of obesity with preserved metabolic health, highlighting sex-specific mechanisms that uncouple obesity from metabolic ...

More millennial women are reaching a transitional age of declining hormones and disruptive symptoms. They’re not suffering in silence.

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.